HIGHLIGHTS   |  April 23, 2020   Experts Address Difficulties in Lung Cancer Management During COVID-19 Pandemic Researchers detailed the challenges presented for lung cancer therapy during the COVID-19 pandemic and how to potentially mitigate them. Read more ADVERTISEMENT   FDA Approves Tucatinib in Combination with Chemotherapy for HER2-Positive Breast Cancer The FDA approved tucatinib in combination with chemotherapy for the treatment of adult patients with advanced forms of HER2-positive breast cancer. Read more   In Case You Missed It

Venetoclax with Azacytidine Improved Overall Survival for Patients with AML Genentech recently announced their phase III study resulted in improved overall survival and composite complete remission rates for patients with previously untreated acute myeloid leukemia. Read more